Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ARRX vs ROCURONIUM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB-ARRX vs ROCURONIUM: Safety Overview

Metric RITUXIMAB-ARRX ROCURONIUM
Total FAERS Reports 347 6,477
Deaths Reported 11 424
Death Rate 3.2% 6.5%
Hospitalizations 21 1,982
Average Patient Age 57.0 yrs 50.3 yrs
% Female Patients 60.6% 52.6%
FDA Approval Date N/A Apr 12, 2017
Manufacturer N/A HF Acquisition Co LLC, DBA HealthFirst
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued